RxDoctor Payments Data

Karrie Patterson, PA

Physician Assistant · Springfield, ORNPI 1346577186

Payments from drug & device makers

$2,937in general payments, 2019–2025

Across 152 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$353
  • AstraZeneca$327
  • AbbVie$308
  • Boehringer Ingelheim$294
  • Lilly USA, LLC$244
  • Otsuka America Pharmaceutical, Inc.$243
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$2,92199%
  • Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,937 in reported general payments places this provider in the 90th percentile of 1,756 physician assistant providers in Oregon.

See all physician assistant providers in Oregon

Medicare billing

Part B allowed, 2024
$14,516
Medicare patients
42
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$22,194
TrulicityDulaglutide11$10,806
JardianceEmpagliflozin12$9,664
Spiriva HandihalerTiotropium Bromide12$9,524
SymbicortBudesonide/Formoterol Fumarate18$4,180
PremarinEstrogens, Conjugated12$1,803
Gabapentin65$1,059
Atorvastatin Calcium78$975
Metoprolol Succinate47$890
Pregabalin34$724
Albuterol Sulfate HfaAlbuterol Sulfate17$693
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$628
Omeprazole60$623
Losartan Potassium52$542
Bupropion Hcl15$514

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$124$23,99741 claims
Lilly USA, LLCTrulicity$244$10,80611 claims
Boehringer IngelheimJardiance$294$9,66412 claims
AstraZenecaSymbicort$327$4,18018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,756 physician assistant providers in Oregon.

Other physician assistant in Springfield

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →